Skip to main content

Advertisement

Figure 3 | Journal of Translational Medicine

Figure 3

From: Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

Figure 3

Anti-tumor activity of IL-1ra gene transduction and over-expression in melanoma xenografts. An IL-1 producing melanoma (SMEL) was mixed at the indicated ratios with the same cell line that was transduced to over-express IL-1ra (SMEL/IL-1ra) ex vivo and injected s.c. into athymic nude mice. There was significant growth inhibition at all tested ratios, indicating a marked paracrine effect of IL-1ra on tumor growth.

Back to article page